Clinical Trial News and Research

RSS

Implantable brain chip could solve obesity epidemic

Scientists have developed tiny brain chips that alter the area of the brain involved in binge eating. The device is now being tested in humans with obesity.

19 Aug 2019

Study explores if fecal transplants can improve outcomes in melanoma patients

A multidisciplinary team at Lawson Health Research Institute is exploring whether fecal transplants can improve outcomes in melanoma patients treated with immunotherapy.

19 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

FDA approves novel device to treat symptoms associated with advanced heart failure

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

18 Aug 2019

Despite failed promises, stem cell advocates again want taxpayers to pony up billions

Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments.

16 Aug 2019

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Mallinckrodt plc, a leading global biopharmaceutical company, today announced publication of results of its Phase 1b clinical trial of StrataGraft, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries.

16 Aug 2019

Targeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

16 Aug 2019

Advanced method to accurately detect low-level somatic mutation in intractable epilepsy

KAIST medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of major focal epilepsy genes accurately and efficiently identified low-level somatic mutations in intractable epilepsy.

16 Aug 2019

Researchers gain new insights into the mechanism of vaccine-induced T cell immunity

A team led by the Walter Reed Army Institute of Research has gained new insights into the mechanism of vaccine-induced T cell immunity utilizing single-cell RNA sequencing and metabolic profiling techniques.

16 Aug 2019

High gluten intake during childhood increases risk of celiac disease

Children are more likely to develop celiac disease if they consume higher-than-average amounts of gluten during the first five years of life.

15 Aug 2019

Joint lubricating fluid triggers pain response from nerve cells in osteoarthritic patients

A team at the University of Cambridge has shown how, in osteoarthritis patients, the viscous lubricant that ordinarily allows our joints to move smoothly triggers a pain response from nerve cells similar that caused by chilli peppers.

14 Aug 2019

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

14 Aug 2019

Chlamydia vaccine shows promise after a successful clinical trial

A vaccine against the sexually transmitted infection (STI) chlamydia is now a substantial step closer to reality after successfully passing its Phase 1 clinical trial.

14 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

SU2C Dream Team to develop new drug combination to stop spread of breast cancer

At a press conference at McGill University today, Stand Up To Cancer Canada, the Canadian Cancer Society, and the Canadian Institutes of Health Research announced the launch of the SU2C Canada Metastatic Breast Cancer Dream Team to pursue the development of a new drug combination that may help stop the spread of breast cancer to other organs of the body.

13 Aug 2019

Clinical Trial News and Research

Implantable brain chip could solve obesity epidemic

Study explores if fecal transplants can improve outcomes in melanoma patients

FDA approves new drug to treat patients with myelofibrosis

FDA approves novel device to treat symptoms associated with advanced heart failure

Despite failed promises, stem cell advocates again want taxpayers to pony up billions

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Targeted pancreatic cancer drug shows promise in clinical trials

Advanced method to accurately detect low-level somatic mutation in intractable epilepsy

Researchers gain new insights into the mechanism of vaccine-induced T cell immunity

High gluten intake during childhood increases risk of celiac disease

Joint lubricating fluid triggers pain response from nerve cells in osteoarthritic patients

New drug to treat pancreatic cancer shows promising results in clinical trial

Chlamydia vaccine shows promise after a successful clinical trial

Roswell Park receives more than $15 million in grants for cancer research

SU2C Dream Team to develop new drug combination to stop spread of breast cancer

Walnut consumption may offer protection against ulcerative colitis, study finds

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

Researchers test new drug to treat patients with chylomicronemia syndrome

Study shows how cigarette smoke drives tumor aggressiveness in head and neck cancer

New method to enhance heart-attack repair using stem cell-derived cardiomyocytes

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer